5th May 2005 15:54
Sinclair Pharma PLC05 May 2005 Sinclair Pharma plc ("Sinclair" or the "Company") Application has been made to the London Stock Exchange for the admission of1,465,388 new ordinary shares of 1p each fully paid, ranking pari passu with theexisting ordinary shares ("Ordinary Shares"), to trading on the AlternativeInvestment Market ("AIM"). These new Ordinary Shares were allotted, under theterms of the transaction, as part of the deferred consideration for theacquisition of New Co Derm SRL (formerly Euroderm R.D.C S.p.A) by the Company,which was announced on 22 December 2004. Trading in the new Ordinary Shares is expected to commence on 6 May 2005. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma